SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-17-001124
Filing Date
2017-05-12
Accepted
2017-05-12 14:27:32
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q medizoneintl10q033117.htm 10-Q 324324
2 EX-31.1 ex31-1.htm EX-31.1 11920
3 EX-31.2 ex31-2.htm EX-31.2 11885
4 EX-32.1 ex32-1.htm EX-32.1 4574
5 EX-32.2 ex32-2.htm EX-32.2 4806
  Complete submission text file 0001185185-17-001124.txt   1999502

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mzei-20170331.xml EX-101.INS 220642
7 XBRL TAXONOMY EXTENSION SCHEMA mzei-20170331.xsd EX-101.SCH 29217
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mzei-20170331_cal.xml EX-101.CAL 24223
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mzei-20170331_def.xml EX-101.DEF 144374
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mzei-20170331_lab.xml EX-101.LAB 211187
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mzei-20170331_pre.xml EX-101.PRE 145519
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 17837916
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries